PT  - JOURNAL ARTICLE
AU  - Brhane Berhe
AU  - Haftom Legese
AU  - Hagos Degefa
AU  - Gebre Adhanom
AU  - Aderajew Gebrewahd
AU  - Fitsum Mardu
AU  - Kebede Tesfay
AU  - Miglas Welay
AU  - Hadush Negash
TI  - Global epidemiology, pathogenesis, immune response, diagnosis, treatment, economic and psychological impact, challenges, and future prevention of COVID-19: A Scoping review
AID  - 10.1101/2020.04.02.20051052
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.02.20051052
4099  - http://medrxiv.org/content/early/2020/04/06/2020.04.02.20051052.short
4100  - http://medrxiv.org/content/early/2020/04/06/2020.04.02.20051052.full
AB  - Background Globally, the novel coronavirus, is a public health problem causing respiratory infections. Since the outbreak of severe acute and Middle East respiratory syndromes coronavirus was not reported to cause human infections. Now, it become an epidemic proportion with growing number of cases and deaths.Methods A scoping review was conducted following the methodological framework. In this scoping review, 50 records published before 28 March, 2020 were included and discussed to better understand the current epidemiology, pathogenesis, immunological response, diagnosis, evasion mechanisms and suggested strategies to boost immune system, challenges, treatment, and future preventions of the virus. PubMed, BioRxiv, MedRxiv, Global Health and google scholars were searched comprehensively for articles, preprints, grey literatures, reports, websites, conference proceedings and expert information. Studies conducted in human and published in English language were included in the analysis. All the findings and statements of the review regarding the outbreak are based on published information as listed in citations.Results We identified 360 records, of which 50 studies met the inclusion criteria. We synthesized the data from the included records and dig out the deep insights of them and pooled into this review. The burden of the outbreak is worsening due to overcrowding, presence of asymptomatic carriers, scarcity of test kits, the immune escaping ability of the virus and lack of awareness.Conclusions and recommendations Due to the fast-spreading nature of COVID-19 the prevention and control strategies become challenging. It is imposing social, psychological, and socio-economic impacts. We recommended that following social distancing, isolation suspects, using personal protective equipment, health education and introducing hand-washing practices, avoiding contact with animals, vaccine development and treatment for controlling and prevention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNot applicableAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are incorporated into the manuscript.ACEAngiotensin converting enzymeCDCluster of differentiationCDCCenter of disease ControlCOPDChronic obstructive pulmonary diseaseCOVID-19Novel corona virus-19MERS-CoVMiddle East respiratory syndromePAMPsPathogen associated molecular patternsPRISMAPreferred Reporting Items for Systematic Reviews and Meta-analyses ProtocolPRRPattern recognition receptorsRNARibonucleic acidSARS-CoVSevere acute respiratory syndromeWHOWorld health organizationTHT helper cellsTLRToll- like receptor